Drug
Methylprednisolone Tablet
Methylprednisolone Tablet is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
33%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (50.0%)
Phase 41 (50.0%)
Trials by Status
completed267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completed
Comparative Effects of Methylprednisolone and Prednisolone on the Risk of Acute Decompensated Heart Failure - An Emulated Target Trial
NCT06468007
completedphase_4
Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease
NCT04988282
unknownphase_2
Efficacy of Steroids on Functional Outcomes After Musculoskeletal Injuries of the Hand
NCT05003596
Clinical Trials (3)
Showing 3 of 3 trials
NCT06468007
Comparative Effects of Methylprednisolone and Prednisolone on the Risk of Acute Decompensated Heart Failure - An Emulated Target Trial
NCT04988282Phase 4
Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease
NCT05003596Phase 2
Efficacy of Steroids on Functional Outcomes After Musculoskeletal Injuries of the Hand
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3